GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cell Biotech Co Ltd (XKRX:049960) » Definitions » Gross-Profit-to-Asset %

Cell Biotech Co (XKRX:049960) Gross-Profit-to-Asset % : 24.29% (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Cell Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Cell Biotech Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₩31,935 Mil. Cell Biotech Co's average Total Assets over the quarter that ended in Mar. 2025 was ₩131,477 Mil. Therefore, Cell Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 24.29%.


Cell Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Cell Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Biotech Co Gross-Profit-to-Asset % Chart

Cell Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.51 32.71 33.19 33.39 29.08

Cell Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.34 30.23 28.24 27.91 24.29

Competitive Comparison of Cell Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Cell Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cell Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Cell Biotech Co's Gross-Profit-to-Asset % falls into.


;
;

Cell Biotech Co Gross-Profit-to-Asset % Calculation

Cell Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=36060.122/( (117640.674+130397.881)/ 2 )
=36060.122/124019.2775
=29.08 %

Cell Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=31935.332/( (130397.881+132556.63)/ 2 )
=31935.332/131477.2555
=24.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Cell Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Cell Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
134 Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-Do, KOR, 415-872
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Cell Biotech Co Headlines

No Headlines